We also found a substantially elevated frequency of TP53 mutations in the subset of BRCA1 methylated tumours, which has not been reported previously, suggesting that BRCA1 methylation might lead to alterations in the same molecular pathways as those known to be commonly altered in familial BRCA1 tumours. The gene discussed is TP53; the disease is neoplasm.